financetom
Business
financetom
/
Business
/
Solesence Q2 revenue rises 56% 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Solesence Q2 revenue rises 56% 
Jul 31, 2025 1:47 PM

Overview

* Solesence ( SLSN ) Q2 revenue rises 56% yr/yr to $20.4 mln

* Net income for Q2 increases to $2.7 mln, aided by Employee Retention Credit

* Company expands debt facilities to support long-term growth initiatives

Result Drivers

* SHIPMENT VOLUME - Shipment volume increased 102% year-over-year, contributing to revenue growth

* PRODUCTION VOLUME - Production volume rose 127% year-over-year, supporting higher revenue

* DEBT FACILITIES - Expanded debt facilities to enhance financial flexibility for growth investments

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Net $2.67

Income mln

Q2 $3.49

Adjusted mln

EBITDA

Q2 Basic $0.04

EPS

Q2 Gross $5.88

Profit mln

Q2 $1.91

Income mln

From

Operatio

ns

Q2 $3.06

Pretax mln

Profit

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Financial
Sector Update: Financial
Aug 19, 2024
08:59 AM EDT, 08/19/2024 (MT Newswires) -- Financial stocks were edging higher pre-bell Monday with the Financial Select Sector SPDR Fund (XLF) up 0.1% recently. B. Riley Financial ( RILY ) shares were down more than 8% after saying its Chair and Co-Chief Executive Bryant Riley has made an unsolicited proposal to take the company private for $7 per share....
--General Motors Laying Off Over 1,000 Salaried Software, Services Workers, CNBC Reports
--General Motors Laying Off Over 1,000 Salaried Software, Services Workers, CNBC Reports
Aug 19, 2024
09:03 AM EDT, 08/19/2024 (MT Newswires) -- Price: 45.45, Change: +0.13, Percent Change: +0.29 ...
Alzamend Neuro Enters Partnership for Phase II Clinical Trial of Potential Lithium Therapeutic Drug for Post-Traumatic Stress Disorder; Shares Soar
Alzamend Neuro Enters Partnership for Phase II Clinical Trial of Potential Lithium Therapeutic Drug for Post-Traumatic Stress Disorder; Shares Soar
Aug 19, 2024
08:59 AM EDT, 08/19/2024 (MT Newswires) -- Alzamend Neuro ( ALZN ) said Monday it is teaming up with Massachusetts General Hospital for a phase II clinical trial of its lithium therapeutic drug candidate for post-traumatic stress disorder. The study of AL001 aims to compare the increase in lithium levels within the brain and its structures versus a commonly marketed...
Sector Update: Tech
Sector Update: Tech
Aug 19, 2024
08:47 AM EDT, 08/19/2024 (MT Newswires) -- Technology stocks were steady premarket Monday, with the SPDR S&P Semiconductor ETF (XSD) inactive and the Technology Select Sector SPDR Fund (XLK) was slightly higher recently. Advanced Micro Devices ( AMD ) shares were up more than 2% after saying it has agreed to acquire artificial intelligence infrastructure provider ZT Systems in a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved